Phase I study of therapy with Y-90-SMT487 (octreother) in patients with somatostatin receptor (SS-R) positive tumors.

Valkema, R; Jamar, François; Pauwels, Stanislas; Kvols, L; Bakker, WH; Smith, C; Krenning, EP

Phase I study of therapy with Y-90-SMT487 (octreother) in patients with somatostatin receptor (SS-R) positive tumors.

Valkema, R

;

Jamar, François

;

Pauwels, Stanislas

;

Kvols, L

;

Krenning, EP

;et.al.

(2002)

Files

No attached file found for this publication.

Details

Authors

Valkema, R
Author
Jamar, FrançoisUCLouvain
Author
Pauwels, StanislasUCLouvain
Author
Kvols, L
Author
Krenning, EP
Author

Affiliations

UCLouvainCliniques universitaires Saint-Luc
UCLouvainMD/MINT - Département de médecine interne

Citations

APA
Chicago
FWB

Valkema, R., Jamar, F., Pauwels, S., Kvols, L., Bakker, W., Smith, C., & Krenning, E. (2002). Phase I study of therapy with Y-90-SMT487 (octreother) in patients with somatostatin receptor (SS-R) positive tumors. The Journal of Nuclear Medicine, 43(5), 33P-33P. (Original work published 2002)